{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:09:25Z","timestamp":1771952965532,"version":"3.50.1"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T00:00:00Z","timestamp":1399507200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0096929","type":"journal-article","created":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T22:17:05Z","timestamp":1399587425000},"page":"e96929","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Add-On Effect of Probucol in Atherosclerotic, Cholesterol-Fed Rabbits Treated with Atorvastatin"],"prefix":"10.1371","volume":"9","author":[{"given":"Yuka","family":"Keyamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chifumi","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Kohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Nozako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Yasufuku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Itabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,5,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"C Baigent","year":"2005","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"C Baigent","year":"2010","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa0800742","article-title":"Simvastatin with or without ezetimibe in familial hypercholesterolemia","volume":"358","author":"JJ Kastelein","year":"2008","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atherosclerosis: a perspective for the 1990s","volume":"362","author":"R Ross","year":"1993","journal-title":"Nature"},{"key":"ref5","first-page":"915","article-title":"Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity","volume":"320","author":"D Steinberg","year":"1989","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI115499","article-title":"Role of oxidized low dencity lipoprotein in atherogenesis","volume":"88","author":"JL Witzum","year":"1991","journal-title":"J Clin Invest"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1172\/JCI112349","article-title":"Probucol inhibits oxidative modification of low density lipoprotein","volume":"77","author":"S Parthasarathy","year":"1986","journal-title":"J Clin Invest"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1073\/pnas.84.16.5928","article-title":"Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia","volume":"84","author":"T Kita","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI117301","article-title":"Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol: I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?","volume":"94","author":"M Sasahara","year":"1994","journal-title":"J Clin Invest"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1055\/s-2008-1065348","article-title":"Antiatherogenic effects of cilostazol and probucol alone, and in combination in low density lipoprotein receptor-deficient mice fed with a high fat diet","volume":"40","author":"T Yoshikawa","year":"2008","journal-title":"Horm Metab Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1055\/s-2001-16940","article-title":"Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice","volume":"33","author":"T Yoshikawa","year":"2001","journal-title":"Horm Metab Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0002-9149(94)90579-7","article-title":"The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST)","volume":"74","author":"G Walldius","year":"1994","journal-title":"Am J Cardiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.atherosclerosis.2009.04.002","article-title":"Where are we with probucol: A new life for an old drug?","volume":"207","author":"S Yamashita","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0735-1097(01)01783-1","article-title":"Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia: Fukuoka Atherosclerosis Trial (FAST)","volume":"39","author":"Y Sawayama","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.5551\/jat.E610","article-title":"Long-term probucol treatment prevents secondary cardiovascular events: a cohort study of patients with heterozygous familial hypercholesterolemia in Japan","volume":"15","author":"S Yamashita","year":"2008","journal-title":"J Atheroscler Thromb"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.atherosclerosis.2011.09.051","article-title":"Probucol therapy improves long-term (>10-year) survival after complete revascularization: a propensity analysis","volume":"220","author":"T Kasai","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s004280050205","article-title":"Survival and cardiovascular pathology of heterozygous Watanabe heritable hyperlipidaemic rabbits treated with pravastatin and probucol on a low-cholesterol (0.03%)-enriched diet","volume":"432","author":"JH Br\u00e4sen","year":"1998","journal-title":"Virchows Arch"},{"key":"ref18","first-page":"2472","article-title":"Combined effect of atorvastatin and probucol on plasma cystatin C levels and severity of coronary lesion in patients with borderline coronary lesion","volume":"125","author":"CJ Ge","year":"2012","journal-title":"Chin Med J (Engl)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1253\/circj.CJ-10-0110","article-title":"Pleiotropic effects of statins. - Basic research and clinical perspectives -","volume":"74","author":"Q Zhou","year":"2010","journal-title":"Circ J"},{"key":"ref20","first-page":"1","article-title":"Practical method for plasma lipoprotein analysis","volume":"6","author":"FT Hatch","year":"1968","journal-title":"Adv Lipid Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"15274","DOI":"10.1016\/S0021-9258(17)36602-4","article-title":"A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholine and polypeptides","volume":"269","author":"H Itabe","year":"1994","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/ATVBAHA.108.164723","article-title":"Transient increase in plasma oxidized LDL during the progression of atherosclerosis in apolipoprotein E knockout mice","volume":"29","author":"R Kato","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1210\/jc.2004-0305","article-title":"Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity","volume":"89","author":"B Hansel","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.5551\/jat.12807","article-title":"Effect of Probucol on Antioxidant Properties of HDL in Patients with Heterozygous Familial Hypercholesterolemia","volume":"19","author":"M Inagaki","year":"2012","journal-title":"J Atheroscler Thromb"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1476-511X-12-166","article-title":"Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits","volume":"12","author":"M Niimi","year":"2013","journal-title":"Lipids Health Dis"},{"key":"ref26","first-page":"529","article-title":"C-reactive protein levels are associated with the progression of atherosclerotic lesions in rabbits","volume":"27","author":"Q Yu","year":"2012","journal-title":"Histol Histopathol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"16H","DOI":"10.1016\/0002-9149(86)90430-3","article-title":"Studies on the mechanism of action of probucol","volume":"57","author":"G Steinberg","year":"1986","journal-title":"Am J Cardiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1254\/jjp.40.123","article-title":"Mode of action of probucol in reducing serum cholesterol in mice","volume":"40","author":"K Tawara","year":"1986","journal-title":"Jpn J Pharmacol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms","volume":"8","author":"M Navab","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12016-008-8095-9","article-title":"Oxidative modification of LDL: its pathological role in atherosclerosis","volume":"37","author":"H Itabe","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1084\/jem.20052321","article-title":"Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging","volume":"203","author":"BJ Wu","year":"2006","journal-title":"J Exp Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1161\/01.CIR.0000015607.33345.1F","article-title":"Importance of NAD(P)H oxidase-mediated oxidative stress and contractile type smooth muscle myosin heavy chain SM2 at the early stage of atherosclerosis","volume":"105","author":"S Itoh","year":"2002","journal-title":"Circulation"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.5551\/jat1994.7.238","article-title":"Lysophosphatidylcholine enhances superoxide anions production via endothelial NADH\/NADPH oxidase","volume":"7","author":"S Takeshita","year":"2000","journal-title":"J Atheroscler Thromb"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2009.05.029","article-title":"Metabolism and atherogenic disease association of lysophosphatidylcholine","volume":"208","author":"G Schmitz","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1161\/01.CIR.99.13.1733","article-title":"Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E-deficient mice: possible mechanisms of action","volume":"99","author":"MH Moghadasian","year":"1999","journal-title":"Circulation"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.atherosclerosis.2009.03.023","article-title":"Pro-atherogenic effects of probucol in apo E-KO mice may be mediated through alterations in immune system: Parallel alterations in gene expression in the aorta and liver","volume":"206","author":"Z Xu","year":"2009","journal-title":"Atherosclerosis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0096929","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T09:07:28Z","timestamp":1648976848000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0096929"}},"subtitle":[],"editor":[{"given":"Michael","family":"Bader","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,5,8]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0096929","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,8]]}}}